TCL Archive Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage February 28, 2014
TCL Archive Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival October 29, 2010